Free tool
FAERS Monitor: Heparin Sodium 2,000 Units and Sodium Chloride 0.9% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018609 or its brand name (Heparin Sodium 2,000 Units and Sodium Chloride 0.9% In Plastic Container, Heparin Sodium). Reports on generic versions are filed under their own applications.
Reports
14,076
Serious
11,068
79% of reports
Hospitalization
5,593
Death reported
2,654
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- heparin-induced thrombocytopenia1,293
- drug ineffective1,046
- off label use788
- nausea754
- drug hypersensitivity643
- vomiting621
- hypotension572
- dyspnoea558
- pulmonary embolism520
- sepsis503
- pyrexia499
- anaemia488
- abdominal pain484
- thrombocytopenia479
- thrombosis458
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 464 |
| 2005 | 225 |
| 2006 | 189 |
| 2007 | 127 |
| 2008 | 1,029 |
| 2009 | 247 |
| 2010 | 472 |
| 2011 | 403 |
| 2012 | 356 |
| 2013 | 329 |
| 2014 | 276 |
| 2015 | 367 |
| 2016 | 402 |
| 2017 | 528 |
| 2018 | 642 |
| 2019 | 801 |
| 2020 | 706 |
| 2021 | 976 |
| 2022 | 1,142 |
| 2023 | 1,254 |
| 2024 | 1,028 |
| 2025 | 998 |
| 2026 | 1,115 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,083 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| heparin-induced thrombocytopeniaSignal | 1,293 | 531.1 | 499.5 | 504,510 |
| thrombosisSignal | 458 | 8.5 | 7.8 | 3,039 |
| pulmonary embolismSignal | 520 | 8.2 | 7.5 | 3,285 |
| sepsisSignal | 503 | 6.8 | 6.2 | 2,467 |
| thrombocytopeniaSignal | 479 | 6.4 | 5.9 | 2,190 |
| drug hypersensitivitySignal | 643 | 5.0 | 4.6 | 2,052 |
| hypotensionSignal | 572 | 4.3 | 3.9 | 1,439 |
| anaemiaSignal | 488 | 3.8 | 3.5 | 1,025 |
| abdominal painSignal | 484 | 3.1 | 2.9 | 698 |
| pyrexiaSignal | 499 | 2.2 | 2.0 | 313 |
| vomiting | 621 | 2.0 | 1.8 | 304 |
| dyspnoea | 558 | 1.5 | 1.4 | 87 |
| nausea | 754 | 1.4 | 1.3 | 98 |
| off label use | 788 | 1.3 | 1.3 | 72 |
| drug ineffective | 1,046 | 1.2 | 1.1 | 32 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.